Table 4.

Treatment of Manifestations in Individuals with 7q11.23 Duplication Syndrome

Manifestation/ConcernTreatmentConsiderations/Other
DD
  • Early intervention programs, special education programs, vocational training
  • Speech-language therapy, PT, OT
Hippotherapy should be considered, esp for children who have difficulty w/balance & children who have ASD.
Childhood apraxia of speech or other significant speech delay/disorder Intensive speech-language therapy (preferably by a speech-language pathologist who has specific training in treating motor speech disorders)To maximize effective oral communication & prevent or limit later language impairment &/or reading disorder
Anxiety /
Selective mutism
  • Cognitive-behavioral intervention for anxiety (preferably by licensed clinical psychologist)
  • Psychotropic medication if indicated
For children who have selective mutism, co-treatment by speech-language therapist & psychologist should be strongly considered.
ASD Applied behavior analysis (preferably conducted by a board-certified behavior analyst) or other empirically supported intervention for ASD
ADHD
  • Behavioral modifications in home & school settings
  • Psychotropic medication if indicated
Aggression
  • Applied behavior analysis intervention
  • Psychotropic medication if indicated
Physical aggression should be assessed & treated immediately to prevent development of a long-standing pattern of aggression.
Oppositionality
  • Behavioral interventions w/emphasis on reinforcing positive behaviors
  • Psychotropic medication if indicated
Maintain awareness of potential role of anxiety & speech &/or language difficulties.
Seizures Standardized treatment w/ASM by experienced neurologist
  • Many ASMs may be effective; none has been demonstrated effective specifically for this disorder.
  • Education of parents/caregivers 1
Hydrocephalus Ventriculo-peritoneal shunting as needed
Congenital heart disease Treatment per cardiologist
Aortic dilatation Beta-blocker therapy in some affected persons per cardiologistSome w/severe aortic dilatation have required surgery. 2
Poor weight gain /
Failure to thrive
  • Feeding therapy
  • Gastrostomy tube placement may be required for persistent feeding issues.
Low threshold for clinical feeding eval &/or radiographic swallowing study if clinical signs or symptoms of dysphagia
Constipation Stool softeners, prokinetics, osmotic agents, or laxatives as neededAggressive mgmt at all ages to prevent encopresis & impaction
Growth hormone deficiency Human growth hormone replacement therapy
Genitourinary malformations Treatment per nephrologist &/or urologist
Abnormal vision &/or strabismus Standard treatment(s) per ophthalmologistCommunity vision services through early intervention or school district
Hearing /
Recurrent otitis
  • Standard treatment of otitis
  • Hearing aids may be helpful per ENT.
Community hearing services through early intervention or school district
Clubfeet Casting & treatment per orthopedist
Family/Community
  • Ensure appropriate social work involvement to connect families w/local resources, respite, & support.
  • Coordinate care to manage multiple subspecialty appointments, equipment, medications, & supplies.
  • Ongoing assessment of need for palliative care involvement &/or home nursing
  • Consider involvement in adaptive sports or Special Olympics.

ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; ASM = anti-seizure medication; DD = developmental delay; OT = occupational therapy; PT = physical therapy

1.

Education of parents/caregivers regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for children diagnosed with epilepsy, see Epilepsy Foundation Toolbox.

2.

From: 7q11.23 Duplication Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.